Kun Tang
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 17
- MicroRNA in disease regulation 15
- Urology top 2%
-
- Kidney Stones and Urolithiasis Treatments 12
- Prostate Cancer Diagnosis and Treatment 12
- Prostate Cancer Treatment and Research 11
- Molecular Biology top 5%
- Circular RNAs in diseases 11
- Nephrology top 5%
-
- Nanoplatforms for cancer theranostics 13
-
- Bladder and Urothelial Cancer Treatments 11
- Journals
- SHILAP Revista de lepidopterología (1 paper)ACS Nano (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Kun Tang
118 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 137
- Cancer Research 1.1k
- Urology 206
- Pulmonary and Respiratory Medicine 918
- Molecular Biology 1.5k
- Nephrology 94
Countries citing papers authored by Kun Tang
This map shows the geographic impact of Kun Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Tang more than expected).
Fields of papers citing papers by Kun Tang
This network shows the impact of papers produced by Kun Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Tang. The network helps show where Kun Tang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kun Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 3 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 15 | |
| 9 | 2024 | 3 | |
| 10 | 2024 | 15 | |
| 11 | 2024 | 12 | |
| 12 | 2023 | 16 | |
| 13 | 2022 | 13 | |
| 14 | 2021 | 24 | |
| 15 | 2021 | 14 | |
| 16 | 2021 | 130 | |
| 17 | 2021 | 8 | |
| 18 | 2020 | 118 | |
| 19 | 2020 | 15 | |
| 20 | 2014 | 166 |
About Kun Tang
Kun Tang is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Urology, having authored 129 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (17 papers), MicroRNA in disease regulation (15 papers), Nanoplatforms for cancer theranostics (13 papers), Kidney Stones and Urolithiasis Treatments (12 papers), Prostate Cancer Diagnosis and Treatment (12 papers), Bladder and Urothelial Cancer Treatments (11 papers), Circular RNAs in diseases (11 papers) and Prostate Cancer Treatment and Research (11 papers). The work is most often cited by research in Cancer Research (1.1k citations), Urology (206 citations) and Pulmonary and Respiratory Medicine (918 citations). Kun Tang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Zhangqun Ye, Hua Xu, Zhiqiang Chen, Haibing Xiao, Xia Ding, Heng Li, Haoran Liu, Yu Gan, Kehua Jiang and Xiaoqi Yang. Their work appears in journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.